Alexander Kolliari-Turner1, Brian Oliver2, Giscard Lima1,3, John P Mills4, Guan Wang1, Yannis Pitsiladis5,6, Fergus M Guppy7,8. 1. Collaborating Centre of Sports Medicine, University of Brighton, Eastbourne, UK. 2. Weightlifting Reporter for www.insidethegames.biz and Weightlifting Venue Media Manager London 2012 Olympic Games and Glasgow 2014 Commonwealth Games, Brighton, UK. 3. Department of Movement, Human and Health Sciences, University of Rome "Foro Italico,", Rome, Italy. 4. School of Sport, Rehabilitation and Exercise Sciences, University of Essex, Colchester, UK. 5. Collaborating Centre of Sports Medicine, University of Brighton, Eastbourne, UK. y.pitsiladis@brighton.ac.uk. 6. Department of Movement, Human and Health Sciences, University of Rome "Foro Italico,", Rome, Italy. y.pitsiladis@brighton.ac.uk. 7. School of Pharmacy and Biomolecular Sciences, University of Brighton, Huxley Building, Lewes Road, Brighton, UK. 8. Centre for Stress and Age-related Disease, University of Brighton, Huxley Building, Lewes Road, Brighton, UK.
Abstract
BACKGROUND: The pervasiveness of doping and findings of anti-doping corruption threaten weightlifting's position at the 2024 Olympic Games. Analysing the practices of doping in weightlifters could identify patterns in doping that assist in future detection. METHODS: We analysed publicly available data on sanctioned athletes/support personnel from the International Weightlifting Federation between 2008 and 2019 and announced retrospective Anti-Doping Rule Violations (ADRVs) from the 2008 and 2012 Olympic Games. RESULTS: There were 565 sanctions between 2008 and 2019 of which 82% related to the detection of exogenous Anabolic Androgenic Steroid (AAS) metabolites and markers indicating endogenous AAS usage. The detection of exogenous AAS metabolites, markers of endogenous AAS usage and other substance metabolites varied by IWF Continental Federation (p ≤ 0.05) with Europe (74%, 11%, 15%) and Asia (70%, 15%, 15%) showing a higher detection of exogenous AAS compared to Pan America (37%, 30%, 33%) and Africa (50%, 17%, 33%). When looking at the 10 most detected substances, the nations with the highest number of sanctions (range 17-35) all had at least one overrepresented substance that accounted for 38-60% of all detected substances. The targeted re-analysis of samples from the 2008 and 2012 Olympic Games due to the discovery of long-term metabolites for exogenous AAS resulted in 61 weightlifters producing retrospective ADRVs. This includes 34 original medallists (9 gold, 10 silver and 15 bronze), the highest of any sport identified by Olympic Games sample re-testing. The exogenous AAS dehydrochloromethyltestosterone and stanozolol accounted for 83% of detected substances and were present in 95% of these samples. CONCLUSION: Based on these findings of regional differences in doping practices, weightlifting would benefit from the targeted testing of certain regions and continuing investment in long-term sample storage as the sensitivity and specificity of detection continues to improve.
BACKGROUND: The pervasiveness of doping and findings of anti-doping corruption threaten weightlifting's position at the 2024 Olympic Games. Analysing the practices of doping in weightlifters could identify patterns in doping that assist in future detection. METHODS: We analysed publicly available data on sanctioned athletes/support personnel from the International Weightlifting Federation between 2008 and 2019 and announced retrospective Anti-Doping Rule Violations (ADRVs) from the 2008 and 2012 Olympic Games. RESULTS: There were 565 sanctions between 2008 and 2019 of which 82% related to the detection of exogenous Anabolic Androgenic Steroid (AAS) metabolites and markers indicating endogenous AAS usage. The detection of exogenous AAS metabolites, markers of endogenous AAS usage and other substance metabolites varied by IWF Continental Federation (p ≤ 0.05) with Europe (74%, 11%, 15%) and Asia (70%, 15%, 15%) showing a higher detection of exogenous AAS compared to Pan America (37%, 30%, 33%) and Africa (50%, 17%, 33%). When looking at the 10 most detected substances, the nations with the highest number of sanctions (range 17-35) all had at least one overrepresented substance that accounted for 38-60% of all detected substances. The targeted re-analysis of samples from the 2008 and 2012 Olympic Games due to the discovery of long-term metabolites for exogenous AAS resulted in 61 weightlifters producing retrospective ADRVs. This includes 34 original medallists (9 gold, 10 silver and 15 bronze), the highest of any sport identified by Olympic Games sample re-testing. The exogenous AAS dehydrochloromethyltestosterone and stanozolol accounted for 83% of detected substances and were present in 95% of these samples. CONCLUSION: Based on these findings of regional differences in doping practices, weightlifting would benefit from the targeted testing of certain regions and continuing investment in long-term sample storage as the sensitivity and specificity of detection continues to improve.
Authors: S Bhasin; T W Storer; N Berman; C Callegari; B Clevenger; J Phillips; T J Bunnell; R Tricker; A Shirazi; R Casaburi Journal: N Engl J Med Date: 1996-07-04 Impact factor: 91.245
Authors: Wilhelm Schänzer; Hans Geyer; Gregor Fusshöller; Natalia Halatcheva; Maxie Kohler; Maria-Kristina Parr; Sven Guddat; Andreas Thomas; Mario Thevis Journal: Rapid Commun Mass Spectrom Date: 2006 Impact factor: 2.419
Authors: Indrani Sinha-Hikim; Stephen M Roth; Martin I Lee; Shalender Bhasin Journal: Am J Physiol Endocrinol Metab Date: 2003-04-01 Impact factor: 4.310
Authors: S Bhasin; L Woodhouse; R Casaburi; A B Singh; D Bhasin; N Berman; X Chen; K E Yarasheski; L Magliano; C Dzekov; J Dzekov; R Bross; J Phillips; I Sinha-Hikim; R Shen; T W Storer Journal: Am J Physiol Endocrinol Metab Date: 2001-12 Impact factor: 4.310
Authors: Wilhelm Schänzer; Sven Guddat; Andreas Thomas; Georg Opfermann; Hans Geyer; Mario Thevis Journal: Drug Test Anal Date: 2013-07-19 Impact factor: 3.345
Authors: Shane Rogerson; Robert P Weatherby; Glen B Deakin; Rudi A Meir; Rosanne A Coutts; Shi Zhou; Sonya M Marshall-Gradisnik Journal: J Strength Cond Res Date: 2007-05 Impact factor: 3.775